5 Potential Winners In The ‘New Normal’ Economy

These 5 companies could give your portfolio a boost. Here’s why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

This week saw the departure of Sir Charlie Bean, Deputy Governor of the Bank of England, and in his final interview he stated that the ‘new normal’ interest rate could be as low as 2.5%.

Part of the reason for this is the vast amount of borrowing that UK businesses and individuals currently have, as well as the economy’s sluggish response to the credit crunch, which together mean that an ‘old normal’ rate of 5% may be a long way off.

With that in mind, here are five shares that could benefit from continued low rates.

GlaxoSmithKline

The last few years have been tough for savers, with savings rates being very low. The ‘new normal’ rate of 2.5%, although better, remains relatively unattractive. So shares that offer both a high yield and impressive dividend growth prospects could turn out to be winners.

One such example is GlaxoSmithKline (LSE: GSK). It currently yields 5.2% but its highly attractive drug pipeline means that long-term profitability prospects are very encouraging. As a result, GlaxoSmithKline’s dividend per share could increase at a brisk pace and make the shares more highly demanded, which could also help the share price to head northwards.

British American Tobacco

One beneficiary of low interest rates are companies with high debt levels. Such a  company is British American Tobacco (LSE: BATS), which currently has a debt to equity ratio of 176% — in other words, for every £1 of equity, the business has £1.76 of debt.

Although this seems high, the stability of British American Tobacco’s revenues makes it manageable, while a low interest rate should help to reduce interest charges, thereby increasing company profits. As with GlaxoSmithKline, a yield of 4.2% should also lead to buoyant demand for shares in the company.

The Retail Sector

Clearly, under ‘new normal’ conditions of low interest rates, there is less incentive to save and more incentive to spend. Therefore, retailers such as Sports Direct (LSE: SPD), Marks & Spencer (LSE: MKS) and Debenhams (LSE: DEB) should stand to benefit.

Certainly, Sports Direct is the best performer of the three at present, with the company set to report five consecutive years of earnings growth next year. It also remains attractive when its valuation and growth potential are taken into account, with a price to earnings growth (PEG) ratio of just 0.7 providing evidence of this.

Meanwhile, Debenhams and Marks & Spencer continue to struggle with their respective top-lines. The turnaround story at Marks & Spencer has disappointed many investors, but progress is being made, albeit slowly and its shares continue to offer strong income — a 4.1% yield — and good value  — a price to earnings (P/E) ratio of 12.7 —  at current levels.

Although shares in Debenhams have fallen heavily over the last six months, it too has potential. Recent news included Sports Direct and Costa Coffee concessions within stores, as well as a renewed focus on the company’s multi-channel offering and international expansion. Trading on a P/E of just 9.3, its shares offer great long-term value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter owns shares in GlaxoSmithKline and Marks & Spencer. The Motley Fool has recommended GlaxoSmithKline.

More on Investing Articles

The flag of the United States of America flying in front of the Capitol building
Investing Articles

3 top S&P 500 growth shares to consider buying for a Stocks and Shares ISA in 2025

Edward Sheldon has picked out three S&P 500 stocks that he believes will provide attractive returns for investors in the…

Read more »

Growth Shares

Can the red hot Scottish Mortgage share price smash the FTSE 100 again in 2025?

The Scottish Mortgage share price moved substantially higher in 2024. Edward Sheldon expects further gains next year and in the…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant growth stocks to consider buying in 2025

Rising prices are back on the macroeconomic radar, meaning growth prospects are even more important for investors looking for stocks…

Read more »

Investing Articles

Why I’ll be avoiding BT shares like the plague in 2025

BT shares are currently around 23% below the average analyst price target for the stock. But Stephen Wright doesn’t see…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

5 Warren Buffett investing moves I’ll make in 2025

I’m planning to channel Warren Buffett in 2025. I won’t necessarily buy the same stocks as him, but I’ll track…

Read more »

Investing Articles

Here’s why 2025 could be make-or-break for this FTSE 100 stock

Diageo is renowned for having some of the strongest brands of any FTSE 100 company. But Stephen Wright thinks it’s…

Read more »

Investing Articles

1 massive Stocks and Shares ISA mistake to avoid in 2025!

Harvey Jones kept making the same investment mistake in 2024. Now he aims to put it right when buying companies…

Read more »

Value Shares

Can Lloyds shares double investors’ money in 2025?

Lloyds shares look dirt cheap today. But are they cheap enough to be able to double in price in 2025?…

Read more »